Delcath Systems Inc.

(NASDAQ: DCTH) Trade

Symbol has changed to a new ticker symbol

(DCTHD)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Contact Information

Website: www.delcath.com
Email: investorrelations@delcath.com
Main Phone: +1 212 489-2100
Address: 1633 Broadway
Address 2: 22nd Floor, Suite C
State: NY
City / Town: New York
Country: US
Postal Code: 10019

Issuer Information

Exchange: NSC
CEO: Gerard J. Michel
Employees: 33
NAICS: Medical Laboratories(621511)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A